UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 998

Sortiert nach

A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma

British journal of haematology, 2004-10, Vol.127 (2), p.165-172

2004

Volltextzugriff (PDF)

Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research

Leukemia, 2012-05, Vol.26 (5), p.1091-1097

2012

Volltextzugriff (PDF)

Serum BCMA levels predict outcomes in MGUS and smoldering myeloma patients

Blood cancer journal (New York), 2021-06, Vol.11 (6), p.120-120, Article 120

2021

Volltextzugriff (PDF)

Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy

Leukemia, 2014-07, Vol.28 (7), p.1529-1536

2014

Volltextzugriff (PDF)

A phase 2 study of pegylated liposomal doxorubicin, bortezomib, dexamethasone and lenalidomide for patients with relapsed/refractory multiple myeloma

Leukemia, 2012-07, Vol.26 (7), p.1675-1680

2012

Volltextzugriff (PDF)

A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

The New England journal of medicine, 2003-06, Vol.348 (26), p.2609-2617

2003

Volltextzugriff (PDF)

Prognostic variables for survival and skeletal complications in patients with multiple myeloma osteolytic bone disease

Leukemia, 2010-05, Vol.24 (5), p.1043-1049

2010

Volltextzugriff (PDF)

Kaposi's Sarcoma-Associated Herpesvirus Infection of Bone Marrow Dendritic Cells from Multiple Myeloma Patients

Science (American Association for the Advancement of Science), 1997-06, Vol.276 (5320), p.1851-1854

1997

Volltextzugriff (PDF)

Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution

The Lancet (British edition), 2000-05, Vol.355 (9218), p.1875-1881

2000

Volltextzugriff (PDF)

Reconstitution of Hematopoiesis after High-Dose Chemotherapy by Autologous Progenitor Cells Generated ex Vivo

The New England journal of medicine, 1995-08, Vol.333 (5), p.283-287

1995

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Bone Metastases

Journal of clinical pharmacology, 2002-11, Vol.42 (11), p.1228-1236

2002

Volltextzugriff (PDF)

In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates

Leukemia, 1998-02, Vol.12 (2), p.220-229

1998

Volltextzugriff (PDF)

Purging of Autologous Peripheral-Blood Stem Cells Using CD34 Selection Does Not Improve Overall or Progression-Free Survival After High-Dose Chemotherapy for Multiple Myeloma: Results of a Multicenter Randomized Controlled Trial

Journal of clinical oncology, 2001-09, Vol.19 (17), p.3771-3779

2001

Volltextzugriff (PDF)

Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis

Oncogene, 2006-10, Vol.25 (49), p.6520-6527

2006

Volltextzugriff (PDF)

A Phase I Trial of CD3/CD28-activated T Cells (Xcellerated T Cells) and Interleukin-2 in Patients with Metastatic Renal Cell Carcinoma

Clinical cancer research, 2003-09, Vol.9 (10), p.3562-3570

2003

Volltextzugriff (PDF)

Zoledronic acid in cancer patients with bone metastases: Results of phase I and II trials

Seminars in oncology, 2001-04, Vol.28 (2 Suppl 6), p.25-34

Berenson, James R

2001

Volltextzugriff (PDF)

The Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Varying Degrees of Renal Function

Journal of clinical pharmacology, 2003-02, Vol.43 (2), p.154-162

2003

Volltextzugriff (PDF)

Safety and Convenience of a 15‐Minute Infusion of Zoledronic Acid

The oncologist (Dayton, Ohio), 2004-01, Vol.9 (3), p.319-329

2004

Volltextzugriff (PDF)

The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement

Leukemia, 2008-08, Vol.22 (8), p.1479-1484

2008

Volltextzugriff (PDF)

Pleiotrophin produced by multiple myeloma induces transdifferentiation of monocytes into vascular endothelial cells: a novel mechanism of tumor-induced vasculogenesis

Blood, 2009-02, Vol.113 (9), p.1992-2002

2009

Volltextzugriff (PDF)

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

The New England journal of medicine, 1996-02, Vol.334 (8), p.488-493

1996

Volltextzugriff (PDF)

The Hematopoietic Stem Cell Antigen, CD34, Is Not Expressed on the Malignant Cells in Multiple Myeloma

Blood, 1994-11, Vol.84 (10), p.3283-3290

1994

Volltextzugriff (PDF)

Ex Vivo Expansion of Enriched Peripheral Blood CD34+ Progenitor Cells by Stem Cell Factor, Interleukin-1β (IL-1β), IL-6, IL-3, Interferon-γ, and Erythropoietin

Blood, 1993-05, Vol.81 (10), p.2579-2584

1993

Volltextzugriff (PDF)

Oral bisphosphonates : A review of clinical use in patients with bone metastases

Cancer, 2000, Vol.88 (1), p.6-14

2000

Volltextzugriff (PDF)

Attenuation of CD4+ T-cell function by human adenovirus type 35 is mediated by the knob protein

Journal of general virology, 2012-06, Vol.93 (Pt 6), p.1339-1344

2012

Volltextzugriff (PDF)

1 – 25 von 998

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(862)
Mit Volltextzugriff
(837)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(558)
Humans
(533)
Life Sciences & Biomedicine
(521)
Biological And Medical Sciences
(317)
Female
(315)
Male
(286)
Medical Sciences
(275)
Adult
(182)
Middle Aged
(138)
Adolescent
(132)
Child
(117)
Hematology
(106)
Oncology
(92)
Risk Factors
(90)
Aged
(87)
Animals
(72)
General & Internal Medicine
(58)
European Continental Ancestry Group
(57)
Immunology
(56)
Medicine, General & Internal
(56)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma

Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research

Serum BCMA levels predict outcomes in MGUS and smoldering myeloma patients

Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy

A phase 2 study of pegylated liposomal doxorubicin, bortezomib, dexamethasone and lenalidomide for patients with relapsed/refractory multiple myeloma

A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

Prognostic variables for survival and skeletal complications in patients with multiple myeloma osteolytic bone disease

Kaposi's Sarcoma-Associated Herpesvirus Infection of Bone Marrow Dendritic Cells from Multiple Myeloma Patients

Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution

Reconstitution of Hematopoiesis after High-Dose Chemotherapy by Autologous Progenitor Cells Generated ex Vivo

Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Bone Metastases

In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates

Purging of Autologous Peripheral-Blood Stem Cells Using CD34 Selection Does Not Improve Overall or Progression-Free Survival After High-Dose Chemotherapy for Multiple Myeloma: Results of a Multicenter Randomized Controlled Trial

Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis

A Phase I Trial of CD3/CD28-activated T Cells (Xcellerated T Cells) and Interleukin-2 in Patients with Metastatic Renal Cell Carcinoma

Zoledronic acid in cancer patients with bone metastases: Results of phase I and II trials

The Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Varying Degrees of Renal Function

Safety and Convenience of a 15‐Minute Infusion of Zoledronic Acid

The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement

Pleiotrophin produced by multiple myeloma induces transdifferentiation of monocytes into vascular endothelial cells: a novel mechanism of tumor-induced vasculogenesis

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

The Hematopoietic Stem Cell Antigen, CD34, Is Not Expressed on the Malignant Cells in Multiple Myeloma

Ex Vivo Expansion of Enriched Peripheral Blood CD34+ Progenitor Cells by Stem Cell Factor, Interleukin-1β (IL-1β), IL-6, IL-3, Interferon-γ, and Erythropoietin

Oral bisphosphonates : A review of clinical use in patients with bone metastases

Attenuation of CD4+ T-cell function by human adenovirus type 35 is mediated by the knob protein

Suchergebnisse filtern